FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40114511000001101: Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2085491000001110 Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2085501000001118 Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Has specific active ingredient Sotorasib true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Has AMP Lumykras 120mg tablets (Amgen Ltd) true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Is a Sotorasib 120mg tablets 240 tablet true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Has specific active ingredient Sotorasib false Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lumykras 120mg tablets (Amgen Ltd) 240 tablet 30 x 8 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start